missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human Aggrecan G1-IGD-G2 Domains Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Enzyme Activity, Binding Activity
Marca: R&D Systems™ 1220-PG-025
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
The Recombinant Human Aggrecan G1-IGD-G2 Domains Protein is derived from NS0. The Recombinant Human Aggrecan G1-IGD-G2 Domains Protein has been validated for the following applications: Enzyme Activity, Binding Activity.Especificaciones
| Lyophilized from a 0.2μm filtered solution in Tris and NaCl. | |
| 74 kDa | |
| 25 μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Recombinant | |
| >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining. |
| 176 | |
| Aggrecan G1-IGD-G2 Domains | |
| Mouse myeloma cell line,NS0-derived human Aggrecan protein Val20-Gly675,with a C-terminal 10-His tag | |
| Unconjugated | |
| For hyaluronan-binding assay, reconstitute at 100 μg/mL in PBS. For use as a metalloprotease substrate, reconstitute at 250 μg/mL in 50 mM Tris, 10 mM CaCl 2 150 mM NaCl and 0.05% Brij-35, pH 7.5. |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido